Skip to main content

Advertisement

SpringerLink
Log in

Loss of microRNA-132 predicts poor prognosis in patients with primary osteosarcoma

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

MicroRNA-132 (miR-132), an angiogenic growth factor inducible microRNA in the endothelium, facilitates pathological angiogenesis. Previous study showed that miR-132 was downregulated in human osteosarcoma. However, its functional attributes associated with tumor progression of osteosarcoma have not been fully elucidated. The aim of this study was to investigate the clinical significance of miR-132 expression in human osteosarcoma. miR-132 expression was detected by quantitative reverse transcription polymerase chain reaction using 166 pairs of osteosarcoma and noncancerous bone tissues. Then, the association of miR-132 expression with clinicopathological factors or survival of osteosarcoma patients was also evaluated. miR-132 expression was significantly lower in osteosarcoma tissues than that in corresponding noncancerous bone tissues (P < 0.001). In addition, miR-132 expression was decreased in the osteosarcoma specimens with advanced clinical stage (P = 0.009), positive distant metastasis (P = 0.006), and poor response to chemotherapy (P = 0.009). Moreover, both the univariate and multivariate analyses showed that osteosarcoma patients with low miR-132 expression had poorer overall and disease-free survival (both P < 0.001), and low miR-132 expression was an independent prognostic factor for both overall (P = 0.001) and disease-free survival (P = 0.006). These findings offer the convinced evidence for the first time that miR-132 may participate in tumor progression of osteosarcoma and loss of miR-132 expression may be a predictor for unfavorable outcome of osteosarcoma patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Maire G, Martin JW, Yoshimoto M, Chilton-MacNeill S, Zielenska M, Squire JA (2011) Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma. Cancer Genet 204:138–146

    Article  PubMed  CAS  Google Scholar 

  2. Ottaviani G, Jaffe N (2009) The epidemiology of osteosarcoma. Cancer Treat Res 152:3–13

    Article  PubMed  Google Scholar 

  3. Teicher BA (2012) Searching for molecular targets in sarcoma. Biochem Pharmacol 84:1–10

    Article  PubMed  CAS  Google Scholar 

  4. Gorlick R (2009) Current concepts on the molecular biology of osteosarcoma. Cancer Treat Res 152:467–478

    Article  PubMed  Google Scholar 

  5. Szuhai K, Cleton-Jansen AM, Hogendoorn PC, Bovée JV (2012) Molecular pathology and its diagnostic use in bone tumors. Cancer Genet 205:193–204

    Article  PubMed  CAS  Google Scholar 

  6. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297

    Article  PubMed  CAS  Google Scholar 

  7. Kim VN (2005) MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6:376–385

    Article  PubMed  CAS  Google Scholar 

  8. Cai Y, Yu X, Hu S, Yu J (2009) A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinform 7:147–154

    Article  CAS  Google Scholar 

  9. Novello C, Pazzaglia L, Cingolani C, Conti A, Quattrini I, Manara MC, Tognon M, Picci P, Benassi MS (2013) miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control. Int J Oncol 42:667–675

    PubMed  CAS  Google Scholar 

  10. Gougelet A, Pissaloux D, Besse A, Perez J, Duc A, Dutour A, Blay JY, Alberti L (2011) Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response. Int J Cancer 129:680–690

    Article  PubMed  CAS  Google Scholar 

  11. Lulla RR, Costa FF, Bischof JM, Chou PM, de Bonaldo FM, Vanin EF, Soares MB (2011) Identification of differentially expressed MicroRNAs in osteosarcoma. Sarcoma 2011:732690

    Article  PubMed  Google Scholar 

  12. Nudelman AS, DiRocco DP, Lambert TJ, Garelick MG, Le J, Nathanson NM, Storm DR (2010) Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132. Hippocampus 20:492–498

    PubMed  CAS  Google Scholar 

  13. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9:189–198

    Article  PubMed  CAS  Google Scholar 

  14. Wong TS, Liu XB, Chung-Wai Ho A, Po-Wing Yuen A, Wai-Man Ng R, Ignace Wei W (2008) Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. Int J Cancer 123:251–257

    Article  PubMed  CAS  Google Scholar 

  15. Anand S, Majeti BK, Acevedo LM, Murphy EA, Mukthavaram R, Scheppke L, Huang M, Shields DJ, Lindquist JN, Lapinski PE, King PD, Weis SM, Cheresh DA (2010) MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat Med 16:909–914

    Article  PubMed  CAS  Google Scholar 

  16. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299:425–436

    Article  PubMed  CAS  Google Scholar 

  17. Yang L, Belaguli N, Berger DH (2009) MicroRNA and colorectal cancer. World J Surg 33:638–646

    Article  PubMed  Google Scholar 

  18. Xu J, Wu S, Shi X (2010) Expression of matrix metalloproteinase regulator, RECK, and its clinical significance in osteosarcoma. J Orthop Res 28:1621–1625

    Article  PubMed  CAS  Google Scholar 

  19. Fan L, Wu Q, Xing X, Wei Y, Shao Z (2012) MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells. Acta Biochim Biophys Sin (Shanghai) 44:407–414

    Article  CAS  Google Scholar 

  20. Cai H, Lin L, Cai H, Tang M, Wang Z (2013) Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma. Med Oncol 30:499

    Article  PubMed  Google Scholar 

  21. Zhao G, Cai C, Yang T, Qiu X, Liao B, Li W, Ji Z, Zhao J, Zhao H, Guo M, Ma Q, Xiao C, Fan Q, Ma B (2013) MicroRNA-221 induces cell survival and cisplatin resistance through PI3 K/Akt pathway in human osteosarcoma. PLoS ONE 8:e53906

    Article  PubMed  CAS  Google Scholar 

  22. Wanet A, Tacheny A, Arnould T, Renard P (2012) miR-212/132 expression and functions: within and beyond the neuronal compartment. Nucleic Acids Res 40:4742–4753

    Article  PubMed  CAS  Google Scholar 

  23. Scott HL, Tamagnini F, Narduzzo KE, Howarth JL, Lee YB, Wong LF, Brown MW, Warburton EC, Bashir ZI, Uney JB (2012) MicroRNA-132 regulates recognition memory and synaptic plasticity in the perirhinal cortex. Eur J Neurosci 36:2941–2948

    Article  PubMed  Google Scholar 

  24. Murata K, Yoshitomi H, Tanida S, Ishikawa M, Nishitani K, Ito H, Nakamura T (2010) Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 12:R86

    Article  PubMed  Google Scholar 

  25. Park JK, Henry JC, Jiang J, Esau C, Gusev Y, Lerner MR, Postier RG, Brackett DJ, Schmittgen TD (2011) miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. Biochem Biophys Res Commun 406:518–523

    Article  PubMed  CAS  Google Scholar 

  26. Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu Z, Liu R, Wu Z (2013) Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Cell Signal 25:1037–1043

    Article  PubMed  CAS  Google Scholar 

  27. Li S, Meng H, Zhou F, Zhai L, Zhang L, Gu F, Fan Y, Lang R, Fu L, Gu L, Qi L (2013) MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. Pathol Res Pract 209:179–183

    Article  PubMed  CAS  Google Scholar 

  28. Formosa A, Lena AM, Markert EK, Cortelli S, Miano R, Mauriello A, Croce N, Vandesompele J, Mestdagh P, Finazzi-Agrò E, Levine AJ, Melino G, Bernardini S, Candi E (2013) DNA methylation silences miR-132 in prostate cancer. Oncogene 32:127–134

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Orthopedics Department, 8th Hospital, Shanghai, 200235, China

    Jie Yang, Tiantian Gao & Shiping Fu

  2. Orthopedics Department, Xuhui Central Hospital, Shanghai, 200031, China

    Jie Tang & Haikang Cai

  3. Orthopedics Department, Zhujiang Hospital The Southern Medical University, Guangzhou, 510282, China

    Lijun Lin

Authors
  1. Jie Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tiantian Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jie Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Haikang Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lijun Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shiping Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shiping Fu .

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, J., Gao, T., Tang, J. et al. Loss of microRNA-132 predicts poor prognosis in patients with primary osteosarcoma. Mol Cell Biochem 381, 9–15 (2013). https://doi.org/10.1007/s11010-013-1677-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-013-1677-8

Keywords

Search

Navigation